Volume 14, Number 12—December 2008

CME ACTIVITY

Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel

Ronit Zaidenstein, Chantal Sadik, Larisa Lerner, Lea Valinsky, June Kopelowitz, Ruth Yishai, Vered Agmon, Michele Parsons, Cheryl Bopp, and Miriam Weinberger 

Author affiliations: Assaf Harofeh Medical Center, Zerifin, Israel (R. Zaidenstein, M. Weinberger); Israel Ministry of Health, Jerusalem, Israel (C. Sadik, L. Lerner, L. Valinsky, J. Kopelowitz, R. Yishai, V. Agmon); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Parsons, C. Bopp); Tel Aviv University, Ramat Aviv, Israel (M. Weinberger)

Main Article

Figure 2

Figure 2. Annual distribution of laboratory-confirmed and suspected Vibrio vulnificus biotype 3 infections.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.